سوق العلاجات المناعية للحساسية – المحركات والاتجاهات والفرص وإحصاءات النمو | 2031

  • Report Code : TIPRE00008219
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 149
Buy Now

قُدرت قيمة سوق العلاجات المناعية للحساسية بـ 1,819.18 مليون دولار أمريكي في عام 2019 ومن المتوقع أن تصل إلى 4,185.89 مليون دولار أمريكي بحلول عام 2027؛ ومن المتوقع أن تنمو بمعدل نمو سنوي مركب قدره 11.1% من عام 2020 إلى عام 2027.

العلاج المناعي للحساسية، والذي يُطلق عليه أيضًا إزالة التحسس أو نقص التحسس، هو علاج طبي يركز على عدة أنواع الحساسية. هناك نمو في انتشار الحساسية، وغالبًا ما تكون التدخلات العلاجية التقليدية، مثل العلاج الدوائي، غير فعالة. ونتيجة لذلك، تزداد شعبية العلاج المناعي للحساسية لعلاج عدة أنواع من الحساسية عن طريق زيادة التحمل المناعي وتغيير مسار المرض. من المتوقع أن ينمو سوق العلاجات المناعية للحساسية بسبب العوامل الدافعة الرئيسية مثل زيادة انتشار اضطرابات الحساسية والتقدم التكنولوجي في تركيبات الجرعات تحت اللسان. ومع ذلك، من المرجح أن تعيق العيوب المرتبطة باستخدام العلاجات المناعية للحساسية والاختلافات التنظيمية عبر المناطق نمو السوق خلال الفترة المتوقعة.

المناطق المربحة للعلاجات المناعية للحساسية السوق


رؤى استراتيجية

رؤى السوق

تزايد انتشار اضطرابات الحساسية< /p>

تعد اضطرابات الحساسية من أكثر المشكلات شيوعًا التي يعالجها أطباء الرعاية الأولية وأطباء الأطفال؛ أكثر من 25% من السكان في الدول المتقدمة يعانون من الحساسية. تشمل الحساسية مجموعة من الاضطرابات التي تتميز بتطور استجابة مناعية مفرطة النشاط لمسبب الحساسية، مما يؤدي إلى استجابة السيتوكينات المستقطبة Th2 لمسبب الحساسية وإنتاج استجابة الجسم المضاد IgE.

< p>يتطلب الانتشار المتزايد لاضطرابات الحساسية العلاج المناعي للحساسية، وهو علاج آمن وفعال ضد مسببات الحساسية مثل حبوب اللقاح وعفن الحشرات والحيوانات، وكذلك لعلاج الربو التحسسي. في التقرير الأخير للمسح الوطني لفحص الصحة والتغذية، كان لدى 54% من السكان استجابات اختبار إيجابية لواحد أو أكثر من مسببات الحساسية. وفقا للأكاديمية الأمريكية للحساسية والربو والحساسية. علم المناعة: يؤثر التهاب الأنف التحسسي على 10-30% من السكان، وقد تؤثر التفاعلات الدوائية الضارة على ما يصل إلى 10% من سكان العالم، وما يقرب من 20% من المرضى في المستشفيات. وفقًا لبيانات مسح المركز الوطني للإحصاءات الصحية الذي أجري في عام 2018، بلغ عدد حالات حساسية الجهاز التنفسي، والحساسية الغذائية، والحساسية الجلدية خلال الـ 12 شهرًا الماضية 7.1 مليون، و4.8 مليون، و9.2 مليون على التوالي.
  • صيدليات البيع بالتجزئة
  • صيدليات الإنترنت
  • حسب الموقع الجغرافي

    • أمريكا الشمالية
      • الولايات المتحدة
      • كندا
      • المكسيك
    • أوروبا
      • فرنسا
      • ألمانيا
      • < li>إيطاليا
      • المملكة المتحدة
      • إسبانيا
    • آسيا والمحيط الهادئ (APAC)
      • الصين
      • الهند
      • كوريا الجنوبية
      • اليابان
      • أستراليا
    • الشرق الأوسط& أفريقيا (MEA)
      • جنوب أفريقيا
      • المملكة العربية السعودية
      • الإمارات العربية المتحدة
    • أمريكا الجنوبية (SAM)< ul>
    • البرازيل
    • الأرجنتين

    الملفات التعريفية للشركة

    • ALK-أبيلó A/S
    • AIMMUNE THERAPEUTICS, INC.
    • LETIPharma
    • Stallergenes Greer
    • HAL Allergy BV
    • جونسون and Johnson Services, Inc.
    • Anergis
    • DBV Technologies
    • Dermapharm Holding
    • علاجات الحساسية
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    Who are the major players in the allergy immunotherapies market?

    The allergy immunotherapy market majorly consists of the players such as ALK-Abelló A/S, AIMMUNE THERAPEUTICS, INC., LETIPharma, Stallergenes Greer, HAL Allergy B.V., Anergis, DBV Technologies, Dermapharm Holding, Allergy Therapeutics, ASIT biotech are among others.

    What are the driving factors for the allergy immunotherapies market across the globe?

    The factors that are driving the growth of the market are increasing prevalence of allergic disorders and rising preference for immunotherapies due to efficacy and cost-effectiveness are expected to boost the growth of the global allergy immunotherapy market.

    What is allergy Immunotherapy?

    Allergy Immunotherapy is an allergy treatment process that involves administering small quantities of allergens into your body and then building up doses slowly over some time until the patient develops immunity. Two types of immunotherapy therapies are available in the market, such as subcutaneous immunotherapy (SCIT), also called allergy shots, and sublingual immunotherapy (SLIT). Individuals with symptoms of allergy and do not respond to conventional medical treatments are the potential targets for allergen immunotherapy.

    The List of Companies - Allergy Immunotherapies Market

    1. ALK-Abelló A/S
    2. AIMMUNE THERAPEUTICS, INC.
    3. LETIPharma
    4. Stallergenes Greer
    5. HAL Allergy B.V.
    6. Johnson and Johnson Services, Inc.
    7. Anergis
    8. DBV Technologies
    9. Dermapharm Holding
    10. Allergy Therapeutics

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports